Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01810900
Other study ID # LG-ABCL002
Secondary ID
Status Terminated
Phase Phase 3
First received March 12, 2013
Last updated March 9, 2016
Start date September 2012
Est. completion date December 2013

Study information

Verified date November 2014
Source LG Life Sciences
Contact n/a
Is FDA regulated No
Health authority South Korea: Korea Food and Drug Administration (KFDA)
Study type Interventional

Clinical Trial Summary

This multicenter, randomized, single-blind study assessed the safety and efficacy of Protescal for the reduction of post-operative adhesion formation following myomectomy.


Description:

The age of the patients participating in the study overed 20 years and included nonpregnant women requiring laparoscopic myomectomy and expected to undergo a second-look laparoscopy as part of their treatment plan 5 weeks after the initial surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 50
Est. completion date December 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria:

- a woman who is over 20 years old

- a woman who needs a laparoscopic myomectomy

Exclusion Criteria:

- a pregnant woman and a nursing mother

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Device:
Protescal


Locations

Country Name City State
Korea, Republic of Hanyang University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
LG Life Sciences

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary presence/absence of postoperative adhesions at second-look procedure at second look laparoscopy after 5 weeks later initial laparoscopic myomectomy Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Completed NCT00624390 - Sepraspray™ Laparoscopic Myomectomy Study N/A
Terminated NCT03935815 - Quadratus Lumborum Nerve Blocks for Myomectomies Phase 1
Completed NCT01530802 - Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy N/A
Recruiting NCT05154279 - The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations N/A
Terminated NCT00672750 - A Retrospective Review Of Outcomes Following Laparoscopic Myomectomy N/A